Sleep-Sensitive Seizure Risk Assessment With Wearable EEGs
NCT: NCT06545643 · RECRUITING
Brief Summary
Epilepsy, a prevalent neurological disorder, affects 40% of patients with uncontrolled seizures despite medications. Sleep disturbance exacerbates epilepsy, and vice versa, but existing literature suffers from limitations. Studies conducted in hospital settings provide only brief observation periods and fail to capture the natural sleep environment. Wearable technology offers a promising solution, providing a nuanced understanding of the relationship between seizures and sleep. The Dreem headband, an EEG-based wearable, is well-suited for such studies, offering ease of use and validated accuracy. This technology enables extended observation periods under stable medication conditions, essential for assessing the complex interplay between sleep and epilepsy. By elucidating the impact of sleep on seizures, the researchers seek to identify patient populations where sleep significantly influences seizure susceptibility, ultimately informing personalized epilepsy treatments.
Frequently Asked Questions
What is Sleep-Sensitive Seizure Risk Assessment With Wearable EEGs?
Sleep-Sensitive Seizure Risk Assessment With Wearable EEGs is a clinical trial registered under NCT06545643. Current status: RECRUITING.
What is the status of NCT06545643?
The current status of NCT06545643 (Sleep-Sensitive Seizure Risk Assessment With Wearable EEGs) is: RECRUITING.
When did Sleep-Sensitive Seizure Risk Assessment With Wearable EEGs start?
Sleep-Sensitive Seizure Risk Assessment With Wearable EEGs started on 2025-05-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.